While every person with the Neurofibromatosis type 1 (NF1) cancer predisposition syndrome is born with a single mutation (genetic change) in one copy of their two NF1 genes, it is not known whether the type of mutation predicts what medical problems might arise in any given individual. Now, researchers at the Washington University NF Center […]
Month: November 2017
Dr. Jacobsen joins the Gutmann Laboratory
Kristen Jacobsen, PhD recently joined the research laboratory of NF Center director, David H. Gutmann, MD, PhD, as a postdoctoral research fellow. Dr. Jacobsen completed her graduate training with Douglas Graham, MD, PhD at the University of Colorado and Emory University, where she investigated the importance of the tumor microenvironment in breast cancer and leukemia […]
Clinical Research Highlight in the NF Center
To better understand how behavioral symptoms develop in children with NF1, Dr. Stephanie Morris is leading a clinical study to measure symptoms of attention deficit, autism, and other behavioral problems in preschool-age children with NF1 aged 2.5 to 6.5 years old. Participation in this study involves the completion of three parent-reported questionnaires (completed during the […]